Evidence map›Paper›PMID 36702544›Full record

SynthesisHeart (British Cardiac Society)2023

Clinical characteristics, evaluation and outcomes of chylopericardium: a systematic review.

Beni Verma, Ashwin Kumar, Nikita Verma, Ankit Agrawal, Abdullah Yesilyaprak, Muhammad M Furqan, Gauranga Mahalwar, Felix Berglund, Sayan Manna, Mary Schleicher and 5 more

Open access · hybridAbstract readSystematic Review
In one paragraph

Synthesis in Heart (British Cardiac Society), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it, 12 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Review
  6. Idiopathic Primary Chylopericardium.Arquivos brasileiros de cardiologia · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Primary Idiopathic Chylopericardium in an Adult Female.Methodist DeBakey cardiovascular journal · 2025
    Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 2 countries.

Beni Verma *Center for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0003-0970-2028
Ashwin Kumar *Center for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0003-3379-847X
Nikita VermaDepartment of Medicine, Baba Farid University of Health Sciences, Faridkot, Punjab, India.
Ankit AgrawalCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Abdullah YesilyaprakCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Muhammad M FurqanCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Gauranga MahalwarCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0002-5101-6024
Felix BerglundCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Sayan MannaMallinckrodt Institute Department of Radiology, Washington University in St Louis School of Medicine, St Louis, Missouri, USA.
Mary SchleicherEIectronic Library Services,Research Innovation and Education, Cleveland Clinic, Cleveland, Ohio, USA.
Pejman Raeisi-GiglouDepartment of Cardiovascuar Medicine, MetroHealth Medical Center, Cleveland, Ohio, USA.
Mohamed NasserDepartment of Cardiovascuar Medicine, MetroHealth Medical Center, Cleveland, Ohio, USA.
Ahmad JabriDepartment of Cardiovascuar Medicine, MetroHealth Medical Center, Cleveland, Ohio, USA.
Tom Kai Ming WangCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA.ORCID 0000-0001-5570-9402
Allan L KleinCenter for the Diagnosis and Treatment of Pericardial Diseases,Section of Cardiovascular Imaging,Department of Cardiovascular Medicine, Heart Vascular and Thoracic Institute, Cleveland Clinic, Cleveland, Ohio, USA kleina@ccf.org.ORCID 0000-0001-9240-8369
Cleveland Clinic · USMetroHealth · USBaba Farid University of Health Sciences · INWashington University in St. Louis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveChylopericardium (CPE) is a rare condition associated with accumulation of triglyceride-rich chylous fluid in the pericardial cavity. Due to minimal information on CPE within the literature, we conducted a systematic review of all published CPE cases to understand its clinical characteristics, management and outcomes.

methodsWe performed a literature search and identified cases of patients with CPE from 1946 until May 2021 in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines. We identified relevant articles for pooled analyses of clinical, diagnostic and outcome data.

resultsA total of 95 articles with 98 patients were identified. Patient demographics demonstrated male predominance (55%), with a mean age of 37±15 years. Time from symptom onset to diagnosis was 5 (Q1 4.5, Q3 14) days, with 74% of patients symptomatic on presentation. Idiopathic CPE (60%) was the most common aetiology. Cardiac tamponade secondary to CPE was seen in 38% of cases. Pericardial fluid analysis was required in 94% of cases. Lymphangiography identified the leakage site in 59% of patients. Medical therapy (total parenteral nutrition, medium-chain triglycerides or octreotide) was undertaken in 63% of cases. In our cohort, 32% progressed towards surgical intervention. During a median follow-up of 180 (Q1 180, Q3 377) days, CPE recurred in 16% of cases. Of the patients with recurrence, 10% were rehospitalised.

conclusionCPE tends to develop in younger patients and may cause serious complications. Many patients fail medical therapy, thereby requiring surgical intervention. Although overall mortality is low, associated morbidities warrant close follow-up and possible reintervention and hospitalisations.

Indexed as

Cardiac TamponadePericardial EffusionAdultFemaleHumansMaleMiddle AgedTriglyceridesYoung AdultTriglyceridescardiac tamponadeechocardiographyMagnetic Resonance Imagingpericardial effusionpericarditis

Identifiers

PMID36702544
PMCPMC10423526
OpenAlexW4318150361

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.